We use our own and third party cookies in order to improve our performance, and to obtain anonymous statistics about the use of the website. By continuing to browse, you authorize their use. In order to change the preferences and to obtain further information, please refer to our cookies policy.

Areas
Menu
en

Who we are

Laboratorios LETI is an independent and family-owned biopharmaceutical research company.
In its different areas of expertise, it seeks to contribute products to society that add value to health care.

LETI has always considered health care as a highly profitable investment rather than an expense to be minimized. Health should not be based primarily on the treatment of disease. Body care, either in health or sickness, vaccination and early diagnosis of disease contributes significantly to improving health and quality of life and reduce the incidence and social cost of illness. Consistent with this philosophy, LETI, in addition to treatment, offers a wide range of products for disease prevention, early diagnosis and special body care.

Jaime Grego
President

Its headquarters are in Barcelona and its industrial plant and allergy research laboratory are in Tres Cantos (Madrid). It has subsidiaries in Germany (Ismaning and Witten, Portugal (Oporto) and since 2013 it is present in the US through Juventio LLC (New Jersey). LETI operates with exclusive distributors in several countries in Europe, Latin America and Africa. 

Research and expertise are critical elements in the strategy of LETI. Having innovative, patented products is essential for international growth in selected market segments. Therefore, LETI devotes between 8 and 10 per cent of its revenue to research and product development.

Internationalization is a key element of our strategy. For a specialized company, entry into foreign markets is a requirement in order to grow, and this is facilitated by having its own products developed through research. Thus, for LETI, internationalization is both a necessity and an opportunity, besides being an important enriching element for its organization.

LETI maintains a strategy of strong partnerships and lasting relationships with companies in the sector to enhance its penetration in foreign markets and expand its product range. Likewise, it collaborates with universities and research centres for research and development inside and outside Spain.

LETI is a founding member of Asebio (Spanish Association of Biotechnology Companies) and EAMG (European Allergens Manufacturers Group). It is a member of Farmaindustria, FENIN (Spanish Federation of Healthcare Technology Companies) and BPI (Bundesverband der Pharmazeutischen Industrie) and contributes to various organizations and non-profit foundations in areas related to health and education.